FAZIO, SERAFINO
 Distribuzione geografica
Continente #
NA - Nord America 5.238
AS - Asia 4.683
EU - Europa 3.887
SA - Sud America 479
Continente sconosciuto - Info sul continente non disponibili 119
AF - Africa 106
OC - Oceania 6
AN - Antartide 1
Totale 14.519
Nazione #
US - Stati Uniti d'America 5.043
SG - Singapore 2.396
RU - Federazione Russa 1.407
VN - Vietnam 738
CN - Cina 728
UA - Ucraina 652
IT - Italia 594
HK - Hong Kong 479
BR - Brasile 394
DE - Germania 294
FR - Francia 247
FI - Finlandia 205
SE - Svezia 118
GB - Regno Unito 117
CA - Canada 114
NL - Olanda 103
IE - Irlanda 69
IN - India 57
JP - Giappone 46
BD - Bangladesh 39
MX - Messico 35
ZA - Sudafrica 33
TR - Turchia 27
AR - Argentina 25
CI - Costa d'Avorio 25
ID - Indonesia 21
TH - Thailandia 19
IQ - Iraq 18
PH - Filippine 17
PL - Polonia 16
EC - Ecuador 15
PK - Pakistan 15
CO - Colombia 14
ES - Italia 14
KR - Corea 14
TW - Taiwan 13
VE - Venezuela 11
MA - Marocco 10
BE - Belgio 9
PY - Paraguay 9
UZ - Uzbekistan 9
BG - Bulgaria 6
CR - Costa Rica 6
JM - Giamaica 6
KE - Kenya 6
RO - Romania 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
SN - Senegal 5
SV - El Salvador 5
TT - Trinidad e Tobago 5
AT - Austria 4
CL - Cile 4
HN - Honduras 4
IR - Iran 4
LT - Lituania 4
NP - Nepal 4
TN - Tunisia 4
AZ - Azerbaigian 3
BB - Barbados 3
CZ - Repubblica Ceca 3
EG - Egitto 3
ET - Etiopia 3
GT - Guatemala 3
HT - Haiti 3
IL - Israele 3
OM - Oman 3
PE - Perù 3
PT - Portogallo 3
SA - Arabia Saudita 3
XK - ???statistics.table.value.countryCode.XK??? 3
AF - Afghanistan, Repubblica islamica di 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BJ - Benin 2
CH - Svizzera 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EU - Europa 2
GE - Georgia 2
GP - Guadalupe 2
JO - Giordania 2
KW - Kuwait 2
MG - Madagascar 2
MY - Malesia 2
NG - Nigeria 2
NI - Nicaragua 2
NO - Norvegia 2
PA - Panama 2
PS - Palestinian Territory 2
UY - Uruguay 2
AL - Albania 1
AQ - Antartide 1
BF - Burkina Faso 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
Totale 14.381
Città #
Singapore 955
Jacksonville 666
San Jose 630
Hong Kong 468
Moscow 362
Chandler 323
Ashburn 220
Beijing 215
Ho Chi Minh City 203
Hanoi 189
Princeton 178
Lauterbourg 169
The Dalles 155
Los Angeles 152
Santa Clara 148
Council Bluffs 118
Naples 105
Buffalo 104
Wilmington 97
Dallas 95
Amsterdam 92
Nanjing 90
Millbury 74
Ottawa 70
New York 60
Kronberg 46
Dublin 45
Tokyo 42
Phoenix 41
Orem 40
Nanchang 38
Boston 35
Redondo Beach 33
Haiphong 32
Norwalk 31
Shenyang 30
Munich 28
Atlanta 27
Da Nang 27
São Paulo 27
Chicago 24
Hebei 23
Changsha 22
Rome 22
Bari 21
Milan 21
Seattle 21
Denver 19
Jiaxing 19
Hefei 18
Brooklyn 17
Mexico City 17
Biên Hòa 16
Frankfurt am Main 16
Helsinki 15
San Francisco 15
Tianjin 14
Warsaw 14
Can Tho 13
Montreal 13
Bologna 12
Chennai 12
Orange 12
Johannesburg 11
Stockholm 11
Boardman 10
Des Moines 10
Elk Grove Village 10
Falls Church 10
Kunming 10
Memphis 10
Belo Horizonte 9
Guangzhou 9
Karachi 9
Lawrence 9
London 9
Quito 9
Turin 9
Ankara 8
Florence 8
Hasselt 8
Houston 8
Miami 8
Poplar 8
Rio de Janeiro 8
Bangkok 7
Boydton 7
Cagliari 7
Campinas 7
El Cajon 7
Hải Dương 7
Mumbai 7
Porto Alegre 7
Salt Lake City 7
Tashkent 7
Toronto 7
Baghdad 6
Caracas 6
Charlotte 6
Hangzhou 6
Totale 7.158
Nome #
Supraphysiological Doses of GH Induce Rapid Changes in Cardiac Morphology and Function. 309
Caso clinico Chilopericardio idiopatico: valutazione a distanza del trattamento chirurgico. 249
Supraphysiological doses of GH induce rapid changes in cardiac morphology and function. 233
Effects of growth hormone on exercise capacity and cardiopulmonary performance in patients with chronic heart failure. 213
Growth hormone deficiency in patients with chronic heart failure and beneficial effects of its correction 170
Impact of hyperthyroidism and its correction on vascular reactivity in humans. 167
Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study. 150
Evaluation, by noninvasive methods, of the effects of acute loss of thyroid hormones on the heart. 146
Chronic treatment with the somatostatin analog octreotide improves cardiac abnormalities in acromegaly 143
A nutraceutical combination improves insulin sensitivity in patients with metabolic syndrome: A randomized, double-blind, placebo-controlled trial 142
Cardiac effects of GH 134
A prospective randomized trial of doxorubicin versus idarubicin in the treatment of advanced breast cancer. 131
Endocrine alterations are the main determinants of cardiac remodelling in restrictive anorexia nervosa 131
Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency 129
Efficacy and safety of valsartan plus hydroclorothiazide for high blood pressure 128
INCREASED ARTERIAL INTIMA-MEDIA THICKNESS IN CHILDHOOD-ONSET GROWTH HORMONE DEFICIENCY. 117
Impairment of lung volumes and respiratory muscle strength in adult patients with growth hormone deficiency 117
Effetti dell'associazione di policosanoli, lievito rosso e berberina sul metabolismo lipidico e la funzione endoteliale: studio randomizzato in doppio cieco controllato con placebo 116
Long term combination treatment for severe idiopathic pulmonary arterial hypertension 115
Cardiac function in patients with pacemaker: a noninvasive study. 114
Usefulness of NT-proBNP in the assessment of patients with aortic or mitral regurgitation. 112
Fourier Analysis in patients with different pacing modes. 111
[The role of the GH/IGF-1 axis in cardiovascular physiopathology and therapy: the lessons from animal studies] 109
L'associazione di Valsartan 160 mg ed Idroclorotiazide 25 mg determina un efficace controllo della pressione arteriosa e migliora significativamente i parametri ecocardiografici, già dopo soli 3 mesi 108
Prospective evaluation of hypertensive patients with carotid kinking and coiling: an ultrasonographic 7-year study. 106
Effects of a nutraceutical combination on left ventricular remodeling and vasoreactivity in subjects with the metabolic syndrome 106
Effycacy and safety of valsartan plus hydroclorothiazide for high blood pressure 105
Insulin resistance: Is it time for primary prevention? 104
Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine 101
Tadalafil in Primary Pulmonary Arterial Hypertension 100
The role of the GH-IGF-I axis in the regulation of myocardial growth: from experimental models to human evidence. 99
The regression of left ventricular hypertrophy and improvement in diastolic filling during antihypertensive therapy with cilazapril . 97
Efficacy of ticlopidine in the prevention of thromboembolic events in patients with VVI pacemakers. 94
Follow-up of a respiratory rate modulated pacemaker. 93
Forum sulla ipertensione polmonare 93
Platelet aggregability in patients with a VVI pacemaker. 92
Insufficienza cardiaca nell'obesità 92
A multicenter evaluation of a single-Pass Lead VDD pacing system. 90
Body composition, Bone metabolism, and heart structure and function in Growth hormone (GH) - Deficient adults before and after GH replacment therapy at low doses. 89
Effects of thyroid hormone on the cardiovascular system 88
Interpretation of the epigenetic signature of facioscapulohumeral muscular dystrophy in light of genotype-phenotype studies 88
Il Canrenoato di potassio nella terapia dello scompenso cardiaco. Valutazione emodinamica. 85
Tadalafil improves quality of life and exercise tolerance in idiopathic pulmonary arterial hypertension. 84
Cardiac structural and functional abnormalities in adul patient with Growth hormone deficiency. 84
Il captopril nel trattamento a lungo termine dell'ipertensione arteriosa: efficacia e tollerabilità. 84
A prospective randomized trial of doxorubicin versus idarubicin in the treatment of advanced breast cancer. 83
Effects of subclinical thyroid dysfunction on the heart. 83
Possibilità diagnostiche della stimolazione cardiaca transesofagea e della ventricolografia radioisotopica nella sindrome di Wolf-Parkinson-White. 83
Letter by Fazio and Carlomagno regarding article, "Heart rate predicts outcomes in an implantable cardioverter-defibrillator population". 83
Attività Antiaterogenica di un’Associazione di Nutraceutici: Studio Randomizzato e Controllato con Placebo. 83
Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine. 82
An exaggerated systolic blood pressure response to exercise is associated with cardiovascular remodeling in subjects with prehypertension. 82
Subclinical hypothyroidism and cardiac function. 81
Atenololo e ipertensione: confronti e associazioni 81
La funzione ventricolare sinistra nella stimolazione programmabile. 81
Valutazione dell'NT-proBNP come marker di disfunzione cardiaca nella stratificazione del rischio dei pazienti con insufficienza cardiaca 80
Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. 79
Effects of thyroid hormone on cardiac function : the relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism. 78
Esperienza Clinica con pacemaker monocatetere VDD Phymos. 78
Exercise and Women's Healt 77
Thyroid Hormones and Cardiovascular System: From Bench to Bedside 77
Prehypertension and elevated risk of cardiovascular disease: physiopathologic mechanisms. 76
Growth Hormone and the heart 74
Rate responsive pacing guided by respiratory rate. Long term results. 74
Prazosina ed atenololo nel trattamento dell'ipertensione arteriosa: confronto e associazione 74
Impaired cardiac performance is a distinct feature of uncomplicated acromegaly 74
Cardiovascular aspects in acromegaly: effects of treatment. 73
Cardiovascular Safety of Acute Recombinant Human Thyrotropin Administration to Patients Monitored for Differentiated Thyroid Cancer. 73
Aldosterone receptor blockade in the management of heart failure 73
Benefits of rate responsive ventricular pacing in patients with chronic atrial fibrillation and low ventricular response. 73
Aldosterone receptors' blockade in the management of heart failure in elderly patients. 73
L'atenololo nella terapia dell'angina pectoris:valutazione mediante test da sforzo al treadmill. 72
Immunodeficienze e malattie immuno-mediate 72
Il bisoprololo nella terapia dell'angina pectoris: confronto in doppio cieco con verapamile. 71
Atenolol and atrial fibrillation: evaluation by systolic time intervals. 71
L'adattamento emodinamico nell'obesita' di grado elevato associata o meno a ipertensione arteriosa. 71
Aterosclerosi carotidea ed ictus aterotrombotico. Attuali prospettive diagnostiche e terapeutiche. 71
L'Arterosclerosi 71
Late onset of hypoxemia due to a pulmonary arteriovenous malformation during selective estrogen receptor modulator therapy. 71
Ruolo dell’asse GH/IGF-I nella fisiopatologia e nella terapia cardiovascolare: lezioni da studi sull’animale. 70
Endocardite reumatica e malattie delle valvole cardiache. 70
L'organizzazione del laboratorio di elettrofisiologia degli anni 90. 70
Efficacia antiaritmica e tollerabilità della Mexiletina slow release in confronto con la Idrochinidina ritardo. 69
Effects of chronic subclinical hyperthyroidism from levothyroxine on cardiac morphology and function 69
atenolol and methyldopa in the treatment of mild moderate hypertension: a double blind comparison and combination with single doses. 68
Risultati a lungo termine del trattamento con Ticlopidina in pazienti con pacemaker permanente. 68
Acebutololo e nifedipina nella terapia dell'ipertensione arteriosa. 68
Heart failure caused by dilated cardiomyopathy: rationale for treatment with growth hormone. 67
Benefits of rate responsive ventricular pacing in patients with chronic atrial fibrillation and low ventricular response. 67
Esperienza clinica con Activitrax. 67
Risultati a medio e lungo termine del trattamento chirurgico isolato dell'arteria coronarica discendente anteriore:a proposito di 81 casi. 66
Diagnosi precoce di un caso di endomiocardiopatia eosinofila di Loeffler. Clinica ed Emodinamica. 66
L'Approccio terapeutico all'ipertensione arteriosa: confronto ed associazioni dell' acebutololo con nifedipina e captopril. 66
L'ischemia miocardica: un problema diagnisrico nei pazienti con pacemaker. La scintigrafia miocardica con test di incremento della frequenza di pacing. 66
Il controllo e la programmazione dei moderni pacemaker. 65
Endogenous subclinical hyperthyrfoidism affects quality of life and cardiac morphology and function in young and middle-aged patients. 65
Cardiac function and sympathetic activity in young diabetics. 64
Ormone della crescita e cuore. 64
Myocarditis and dilated cardiomyopathy: possible connections and treatments. 64
Evidence for biventricular involvement in acromegaly: a Doppler echocardiographic study. 63
Totale 9.568
Categoria #
all - tutte 52.808
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.808


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022512 0 0 6 5 10 21 3 39 42 44 184 158
2022/2023893 191 52 27 64 105 80 14 60 155 94 39 12
2023/2024609 27 93 82 26 40 32 16 92 8 7 122 64
2024/20253.311 262 256 44 32 53 102 427 150 373 365 976 271
2025/20265.740 712 426 523 394 978 265 611 423 831 328 118 131
2026/2027887 444 290 153 0 0 0 0 0 0 0 0 0
Totale 14.519